Related Experiment Video
Updated: Jul 16, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
National Psoriasis Foundation clinical consensus on disease severity
David M Pariser1, Jerry Bagel, Joel M Gelfand
1Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA.
Archives of Dermatology
|February 21, 2007
Summary
A new 2-tiered system for classifying psoriasis severity is proposed to better align with clinical practice and guide treatment decisions for plaque psoriasis patients.
Area of Science:
- Dermatology
- Clinical Practice Guidelines
Background:
- Current psoriasis severity criteria (mild, moderate, severe) may not accurately reflect clinical practice.
- A need exists for improved categorization to guide therapeutic interventions.
Purpose of the Study:
- To evaluate existing psoriasis severity criteria.
- To propose a revised 2-tiered system for classifying psoriasis severity.
- To align severity classification with treatment intent.
Main Methods:
- A task force of the National Psoriasis Foundation Medical Board was convened.
- The task force reviewed existing psoriasis severity criteria and consensus statements.
- Expert opinion and current standards of care informed the development of the new system.
Main Results:
- A 2-tiered system for plaque psoriasis severity is proposed.
- This system aims to more accurately reflect patient treatment in clinical settings.
Conclusions:
- The proposed 2-tiered system offers a more accurate reflection of clinical practice for plaque psoriasis.
- This classification aims to aid healthcare professionals and payers in selecting appropriate therapies.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...